Streptomycin(STR) antibody/antigen (BSA/OVA/KLH conjugated hapten)
anti-Streptomycin(STR) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)
Go to Antibiotics diagnostics products collection >>
Product information
Catalog No. | Description | US $ Price (per mg) |
---|---|---|
GMP-SMT-15-1 | 1. BSA-Streptomycin(STR) 2. Anti-Streptomycin(STR) mouse monoclonal antibody | $2709.00 |
GMP-SMT-15-2 | 1. OVA-Streptomycin(STR) 2. Anti-Streptomycin(STR) mouse monoclonal antibody | $2709.00 |
GMP-SMT-15-3 | 1. BSA-Streptomycin(STR) 2. Anti-Streptomycin(STR) human monoclonal antibody | $2709.00 |
GMP-SMT-15-4 | 1. OVA-Streptomycin(STR) 2. Anti-Streptomycin(STR) human monoclonal antibody | $2709.00 |
GMP-SMT-15-Ag-1 | BSA-Streptomycin(STR) | $756.00 |
GMP-SMT-15-Ag-2 | OVA-Streptomycin(STR) | $756.00 |
GMP-SMT-15-Ab-1 | Anti-Streptomycin(STR) mouse monoclonal antibody | $1953.00 |
GMP-SMT-15-Ab-2 | Anti-Streptomycin(STR) human monoclonal antibody | $1953.00 |
Size: 1mg | 10mg | 100mg
Product Description
BSA-Streptomycin(STR)
Cat No. | GMP-SMT-15-Ag-1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates BSA-Streptomycin(STR) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Streptomycin(STR) had been validated with our anti-Hapten antibody Anti-Streptomycin(STR) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
OVA-Streptomycin(STR)
Cat No. | GMP-SMT-15-Ag-2 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; |
Products description | Competitive immunoassay-validated hapten-carrier conjugates OVA-Streptomycin(STR) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Streptomycin(STR) had been validated with our anti-Hapten antibody Anti-Streptomycin(STR) mouse monoclonal antibody via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Streptomycin(STR) mouse monoclonal antibody
Cat No. | GMP-SMT-15-Ab-1 |
Host of Antibody | Mouse IgG |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.4-0.5 |
Products description | The anti-Hapten antibody against hapten Streptomycin(STR) had been validated with our hapten hapten-carrier conjugates BSA-Streptomycin(STR) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Anti-Streptomycin(STR) human monoclonal antibody
Cat No. | GMP-SMT-15-Ab-2 |
Host of Antibody | Human IgG1 |
Bioactivity validation | Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody; Lateral flow immunoassay (LFIA); |
ELISA IC50 (ppb) | 0.4-0.5 |
Products description | The anti-Hapten antibody against hapten Streptomycin(STR) had been validated with our hapten hapten-carrier conjugates BSA-Streptomycin(STR) via competitive ELISA test. |
Application | ELISA tests and other immunoassays; Lateral flow immunoassay (LFIA); LTIA Immunonephelometry Time-resolved Fluorescence Immunoassay (TRFIA) |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Validation Data
Click to get more Data / Case study about the product.
Biomarker Information
1. Streptomycin (STR) in Veterinary Medicine
Streptomycin (STR) is a critical component of the veterinarian's arsenal, classified as an aminoglycoside antibiotic. It is a small molecule that has found extensive application in the field of veterinary medicine. This versatile antibiotic is celebrated for its efficacy in combatting bacterial infections in various animal species. In this comprehensive exploration, we delve into the multifaceted role of STR in veterinary medicine and the broader implications of its use.
1.1 Application in Veterinary Practice
Veterinarians frequently turn to STR to address bacterial infections in animals. It is particularly valuable in the management of infections in livestock, including cattle, poultry, and swine. STR's mode of action involves inhibiting bacterial protein synthesis, making it effective against a broad spectrum of susceptible bacteria. Its application can be lifesaving for animals afflicted by conditions like bovine respiratory disease, avian mycoplasmosis, and other bacterial infections that can threaten animal health and productivity.
1.2 Regulatory Oversight and Residue Concerns
The use of STR in veterinary medicine is subject to stringent regulations and guidelines. These regulations are crucial in maintaining the safety of food products derived from treated animals. When STR is administered to animals, residues of the antibiotic may persist in their tissues and products like meat, milk, and eggs. Monitoring and controlling these residues are essential to ensure the safety of the human food supply chain.
Excessive STR residues in food products can have adverse effects on human health, including the development of antibiotic resistance. To address these concerns, regulatory agencies have established Maximum Residue Limits (MRLs) for STR in various food products. These limits serve as legal thresholds beyond which the presence of STR is considered unacceptable.
1.3 Ensuring Animal Health and Productivity
In addition to its role in maintaining food safety, STR contributes significantly to animal health and productivity. By effectively treating bacterial infections, it helps prevent disease spread within animal populations, reduces morbidity and mortality, and ensures that livestock remain healthy and productive. Healthy animals are more likely to meet their growth potential and yield high-quality products.
2. The Necessity of Quantifying Streptomycin (STR)
Accurate measurement and quantification of STR are imperative for several compelling reasons:
2.1 Ensuring Residue Monitoring
One of the primary reasons for measuring STR content in food products derived from treated animals is to adhere to food safety regulations. This practice safeguards consumers from potential health risks associated with excessive STR residues. Regular monitoring and quantification of STR residues help ensure that these residues are within acceptable limits, mitigating the risk of antibiotic resistance development in human populations.
2.2 Evaluating Treatment Efficacy
Veterinarians and livestock producers rely on precise measurements of STR to assess the effectiveness of treatment protocols. The ability to accurately quantify STR levels in animal tissues and products enables them to make informed decisions regarding treatment adjustments. This is critical for optimizing therapeutic outcomes and minimizing the risk of under- or over-medication, which can lead to treatment failures or potential antibiotic resistance.
2.3 Maintaining Quality Control
Within the pharmaceutical and biopharmaceutical sectors, the accurate measurement of STR content is indispensable during the manufacturing of antibiotic formulations. This meticulous quantification ensures the quality and consistency of final products, which is paramount for drug safety and efficacy. Variations in the concentration of active pharmaceutical ingredients, including STR, can lead to suboptimal therapeutic outcomes and potential risks to patients. Therefore, precise measurement is a cornerstone of quality control in pharmaceutical manufacturing.
2.4 Facilitating Research and Development
Scientists and researchers often necessitate accurate STR measurements for diverse studies. These studies encompass investigations into antibiotic resistance mechanisms, drug development endeavors, and pharmacokinetic assessments. Accurate quantification of STR in biological samples is essential for the success of these studies, enabling researchers to draw meaningful conclusions and contribute to the advancement of veterinary medicine and antimicrobial research.
2.5 Ensuring Regulatory Compliance
Compliance with regulations and guidelines governing the usage of STR in veterinary medicine and food production is of paramount importance. Adherence to established MRLs and other regulatory standards is essential to safeguard animal and human health, as well as to maintain the integrity of the food supply chain. Precise STR measurements are crucial for demonstrating compliance and ensuring that prescribed limits are rigorously adhered to, thus preventing potential legal and health-related issues.
In summary, precise measurement of Streptomycin (STR) content is fundamental for various aspects of veterinary medicine, pharmaceutical quality control, research, and regulatory compliance. This meticulous quantification ensures the safety and effectiveness of diverse applications while addressing concerns related to antibiotic resistance and the safety of food products derived from treated animals. Accurate measurement techniques, such as those offered by Genemedi's anti-Small Molecule antibodies and competitive antigens, are crucial in this endeavor.
About GDU
GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.